FDA Panel Recommends Second Chance for New Class of Painkillers

MONDAY, March 12 (HealthDay News) — A U.S. Food and Drug Administration advisory panel recommended on Monday that the makers of a new class of painkillers be given a second chance to develop the powerful drugs, despite concerns about joint failures.